1. Is percutaneous access superior to cutdown access for endovascular abdominal aortic aneurysm repair? A meta-analysis.
- Author
-
Bi, Guoshan, Wang, Quanwen, Xiong, Guozuo, Chen, Jie, Luo, Dongyang, Deng, Jiangbei, and Qin, Xiao
- Abstract
Objective: The objective is to investigate whether percutaneous access (pEVAR) is superior to cutdown access (cEVAR) in terms of safety and efficacy during endovascular repair of abdominal aortic aneurysms (AAAs). Methods: We searched PubMed, Embase, and Cochrane Library from January 1999 to December 2020 for studies reporting on the comparison between percutaneous and cutdown techniques for endovascular repair of AAAs. Outcomes evaluated were technical success rates, access site-related complications and operative time, and hospital stay. Results: Four randomized controlled trials and nine observational studies with a total of 1683 patients comprising 2715 groin accesses were eligible for the meta-analysis. pEVAR was associated with a lower risk of overall complications (odds ratio (OR) = 0.63; p =.005) and seroma/lymphorrhea (OR, 0.18; p =.0001) and shortened operation time (MD = −39.04; p =.002) and the length of hospital stay (MD = −0.75; p <.00001) compared with cEVAR. The technical success rate for pEVAR was 95.1% (694/729), with an overall OR of 0.27 (95% CI 0.14–0.55, p =.0003) comparing pEVAR with cEVAR. Furthermore, pEVAR did not increase the risk of site infection, femoral artery thrombosis, postoperative hematoma, nerve injury, dissection, and bleeding. Conclusion: Percutaneous endovascular aneurysm repair is a safe and effective method for the treatment of AAA. It reduces the risk of overall complications and shortens the operation time and hospital stay. The technical success rate of pEVAR is lower than that of cEVAR, which may be linked to the selection of patients, operator experience, and the use of ultrasound. Large definitive trials are required to draw robust conclusions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF